RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients (Q34976827)

5 August 2017

RASSF1A methylation indicates a poor prognosis in hepatoblastoma patients (English)

1 reference

5 August 2017

1 reference

Shohei Honda

1

1 reference

5 August 2017

Hisayuki Miyagi

2

1 reference

5 August 2017

Hiromu Suzuki

3

1 reference

5 August 2017

Masashi Minato

4

1 reference

5 August 2017

Masayuki Haruta

5

1 reference

5 August 2017

Yasuhiko Kaneko

6

1 reference

5 August 2017

Kanako C Hatanaka

7

1 reference

5 August 2017

Eiso Hiyama

8

1 reference

5 August 2017

Takehiko Kamijo

9

1 reference

5 August 2017

Tadao Okada

10

1 reference

5 August 2017

Akinobu Taketomi

11

1 reference

5 August 2017

1 November 2013

1 reference

Pediatric Surgery International

5 August 2017

1 reference

5 August 2017

29

1 reference

5 August 2017

11

1 reference

5 August 2017

1147-1152

1 reference

https://scigraph.springernature.com/pub.10.1007/s00383-013-3371-z

5 August 2017

0 references

cites work

Hepatoblastoma: recent developments in research and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

The methylation status of RASSF1A promoter predicts responsiveness to chemotherapy and eventual cure in hepatoblastoma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Outcome of hepatoblastomas treated using the Japanese Study Group for Pediatric Liver Tumor (JPLT) protocol-2: report from the JPLT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Pretreatment prognostic factors for children with hepatoblastoma-- results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Wnt signaling and telomerase activation of hepatoblastoma: correlation with chemosensitivity and surgical resectability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Role of the Ras-association domain family 1 tumor suppressor gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Hepatic Stem-like Phenotype and Interplay of Wnt/β-Catenin and Myc Signaling in Aggressive Childhood Liver Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00383-013-3371-Z

Methylation of the RASSF1A promoter is predictive of poor outcome among patients with Wilms tumor

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23989600

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00383-013-3371-Z

1 reference

Dimensions Publication ID

5 August 2017

0 references

1 reference